What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Antibody
Walter Knapp focuses on Molecular biology, Immunology, Antigen, Myeloid and Cell biology.
When carried out as part of a general Molecular biology research project, his work on Glycoprotein is frequently linked to work in Population, therefore connecting diverse disciplines of study.
His Immunology study frequently involves adjacent topics like Receptor.
His Antigen study incorporates themes from Antibody, Monoclonal antibody and Beta-2 microglobulin.
The concepts of his Myeloid study are interwoven with issues in Haematopoiesis, Immunophenotyping, Leukemia, Acute leukemia and CD33.
His studies deal with areas such as In vitro, CD86, Cytokine, CD40 and Antigen presentation as well as Cell biology.
His most cited work include:
- Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). (1153 citations)
- GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. (739 citations)
- Epidermal Langerhans cells bear Fc and C3 receptors. (490 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Molecular biology, Antigen, Monoclonal antibody and Antibody.
His Immunology research integrates issues from Progenitor cell and Internal medicine.
His research integrates issues of Endocrinology, T cell, IL-2 receptor, Receptor and CD3 in his study of Molecular biology.
His work deals with themes such as Phenotype, Biochemistry, Human leukocyte antigen, Epitope and Cell surface receptor, which intersect with Monoclonal antibody.
Walter Knapp has researched Antibody in several fields, including Interleukin 2, Cell and Pathology.
Walter Knapp works mostly in the field of Myeloid, limiting it down to concerns involving Haematopoiesis and, occasionally, CD34, Cellular differentiation and Cancer research.
He most often published in these fields:
- Immunology (41.88%)
- Molecular biology (40.17%)
- Antigen (26.92%)
What were the highlights of his more recent work (between 1995-2013)?
- Molecular biology (40.17%)
- Immunology (41.88%)
- Cell biology (19.66%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Molecular biology, Immunology, Cell biology, T cell and Cytokine.
The various areas that Walter Knapp examines in his Molecular biology study include Cell, Progenitor cell, Stem cell factor, Antigen and CD3.
In his research, Bone marrow is intimately related to Haematopoiesis, which falls under the overarching field of Progenitor cell.
Immunology is closely attributed to Cancer research in his study.
His Cell biology study integrates concerns from other disciplines, such as In vitro, CD86, Cellular differentiation and Antigen presentation.
His studies examine the connections between Cytokine and genetics, as well as such issues in Tumor necrosis factor alpha, with regards to Acquired immune system.
Between 1995 and 2013, his most popular works were:
- Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. (398 citations)
- TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. (279 citations)
- B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy (240 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Antibody
Cell biology, Molecular biology, Immunology, CD86 and CD34 are his primary areas of study.
His studies in Cell biology integrate themes in fields like Dendritic cell, In vitro and Cytokine.
His Molecular biology research incorporates elements of Membrane protein and Antigen.
His research links Mutation with Immunology.
His research in CD34 intersects with topics in Progenitor cell and Haematopoiesis.
His work focuses on many connections between Haematopoiesis and other disciplines, such as Myeloid, that overlap with his field of interest in CD33.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
